Sarah E Rutstein
Overview
Explore the profile of Sarah E Rutstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rutstein S, Limarzi-Klyn L, Miller W, Powers K
Curr Opin HIV AIDS
. 2025 Feb;
PMID: 39969389
Purpose Of Review: The earliest months of HIV infection are characterized by high viral loads and elevated transmissibility, particularly during the acute (preseroconversion) phase. Transmission prevention during early HIV requires...
2.
Tuan L, Pham L, Khuyen T, Hao B, Hoa N, Vu K, et al.
AIDS Behav
. 2025 Feb;
PMID: 39928069
Retention and adherence to daily oral pre-exposure prophylaxis (PrEP) are critical for effective HIV prevention; however, YMSM exhibit lower rates of both compared to other populations. This is important because...
3.
Rutstein S, Lopez C, Davy-Mendez T, Agarwal H, Huffstetler H, Perhac A, et al.
Int J STD AIDS
. 2024 Oct;
36(1):47-55.
PMID: 39361721
Long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) extends dosing intervals from daily to every 8 weeks. Equitable implementation requires anticipating and addressing barriers to use. We described LAI-CAB/RPV eligibility and initiation among...
4.
Saidi F, Shah S, Squibb M, Chinula L, Nakanga C, Mvalo T, et al.
BMC Public Health
. 2024 Sep;
24(1):2604.
PMID: 39334032
Background: Incident HIV during the perinatal period significantly impedes elimination of Mother-to-Child HIV Transmission (eMTCT) efforts. Pre-Exposure Prophylaxis (PrEP) effectively reduces HIV acquisition, and new agents like injectable Cabotegravir (CAB-LA)...
5.
Nguyen M, Rutstein S, Hoffman I, Tran H, Giang L, Go V
AIDS Behav
. 2024 Sep;
29(2):401-410.
PMID: 39266888
Little is known about HIV testing, pre-exposure prophylaxis (PrEP) awareness and uptake among adolescent and young men who have sex with men (AYMSM) in Vietnam. We conducted an online survey...
6.
Bell G, Chen J, Maierhofer C, Matoga M, Rutstein S, Lancaster K, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(5):450-459.
PMID: 39250334
Background: Detection of acute (preseroconversion) HIV infection (AHI), the phase of highest transmission risk, requires resource-intensive RNA- or antigen-based detection methods that can be infeasible for routine use. Risk score...
7.
Bui H, Giang L, Chen J, Sripaipan T, Nong H, Nguyen N, et al.
Trials
. 2024 Aug;
25(1):552.
PMID: 39164770
Background: In Vietnam and other global settings, men who have sex with men (MSM) have become the population at greatest risk of HIV infection. Although HIV pre-exposure prophylaxis (PrEP) has...
8.
Agarwal H, Huffstetler H, Lopez C, Go V, Napravnik S, Farel C, et al.
AIDS Patient Care STDS
. 2024 Jun;
38(7):324-329.
PMID: 38860413
As access to long-acting injectable antiretroviral therapy (LAI ART) expands, understanding patient perceptions and experiences around LAI should inform equitable scale-up and effective implementation strategies. This study used qualitative research...
9.
Meek C, Munkhondya T, Mphande M, Tembo T, Chitani M, Jean-Baptiste M, et al.
BMC Health Serv Res
. 2024 May;
24(1):606.
PMID: 38720312
Background: Assisted index case testing (ICT), in which health care workers take an active role in referring at-risk contacts of people living with HIV for HIV testing services, has been...
10.
Rutstein S, Muessig K
Curr HIV/AIDS Rep
. 2024 Mar;
21(2):52-61.
PMID: 38517670
Purpose Of Review: Despite highly effective biomedical HIV pre-exposure prophylaxis (PrEP) options, suboptimal PrEP uptake impedes progress towards ending the epidemic in the United States of America (USA). Implementation science...